Featured Research

from universities, journals, and other organizations

Interferon Or Surgery For Eye Surface Cancer – Which Is Best?

Date:
August 1, 2008
Source:
American Academy of Ophthalmology
Summary:
Scientists evaluated 29 patients who were treated within a 10-year period for ocular surface squamous neoplasia (OSSN), a type of cancer, either by surgical removal of the tumor or with topical interferon (alfa-2b).

James Chodosh, MD, and colleagues evaluated 29 patients who were treated within a 10-year period for ocular surface squamous neoplasia (OSSN), a type of cancer, either by surgical removal of the tumor or with topical interferon (alfa-2b).

Related Articles


There were no statistically significant differences in age, gender-affected eye and tumor size between patients in the two groups. Risk factors for this form of cancer include advanced age, light skin, extensive UV-light exposure, smoking, and exposure on the job to petroleum products. HPV (human papilloma virus) and HIV have also been associated with higher rates of OSSN.

Fourteen of the study patients opted for surgical excision; in all cases an aggressive removal of the tumor, with wide and deep margins around the tumor site, was followed by cryotherapy. The aggressive approach was used because more conservative excisions had been associated with high OSSN recurrence rates in other patients.

This is the first report on results of this aggressive approach. Eight study patients received simultaneous reconstruction of the ocular surface using amniotic membrane. Fifteen study patients were treated with interferon; two of these did not respond to treatment and were treated surgically. All patients in both treatment groups eventually experienced complete resolution of their OSSN without recurrence, and with no significant side effects of treatment in either group. Dr. Chodosh says these results suggest that "topical interferon alfa-2 b and aggressive surgical excision can both be considered effective treatments for OSSN."

This research was published in the August issue of Ophthalmology.


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Ophthalmology. "Interferon Or Surgery For Eye Surface Cancer – Which Is Best?." ScienceDaily. ScienceDaily, 1 August 2008. <www.sciencedaily.com/releases/2008/08/080801152131.htm>.
American Academy of Ophthalmology. (2008, August 1). Interferon Or Surgery For Eye Surface Cancer – Which Is Best?. ScienceDaily. Retrieved March 29, 2015 from www.sciencedaily.com/releases/2008/08/080801152131.htm
American Academy of Ophthalmology. "Interferon Or Surgery For Eye Surface Cancer – Which Is Best?." ScienceDaily. www.sciencedaily.com/releases/2008/08/080801152131.htm (accessed March 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, March 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) — The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) — In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins